Literature DB >> 7724753

Quantitative evaluation of pancreatic enhancement during dual-phase helical CT.

M D Hollett1, M J Jorgensen, R B Jeffrey.   

Abstract

PURPOSE: To determine the improvement in pancreatic enhancement at helical computed tomography (CT) performed with an early delay after administration of contrast material compared with that performed with a standard delay.
MATERIALS AND METHODS: Dual-phase helical CT of the abdomen was performed in 120 patients with a 150-mL bolus of contrast material infused at 5 mL/sec. Early and standard delayed scanning was performed beginning at 20 seconds and 49-71 seconds, respectively. Regions of interest were measured in the head, body, and tail of the pancreas in 92 patients. The difference in enhancement between early and standard delayed scanning was calculated.
RESULTS: Mean pancreatic enhancement was 82 HU +/- 3 (standard error) with an early delay, whereas enhancement on standard delay scans was 62 HU +/- 2 (P < .001). An improvement in enhancement greater than 10 HU was attained in 66 of 92 cases (72%).
CONCLUSION: Pancreatic enhancement at helical CT with an early delay after contrast material administration is often significantly greater than the enhancement seen with a standard delay when a monophasic, rapidly infused bolus of contrast material is used.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7724753     DOI: 10.1148/radiology.195.2.7724753

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

1.  Very-high-flow injection rate for upper abdominal CT angiography.

Authors:  Masashi Kimura; Yasukazu Shioyama; Toshiyuki Okumura; Kouji Yamada; Michihisa Kawashima; Hiroki Minamiguti; Takami Hagihira; Kazushi Kishi; Morio Sato
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

Review 2.  Clinical significance of vascular assessment by contrast-enhanced harmonic ultrasonography of pancreatic carcinomas.

Authors:  Masayuki Kitano
Journal:  J Gastroenterol       Date:  2005-06       Impact factor: 7.527

3.  Sixty-four MDCT achieves higher contrast in pancreas with optimization of scan time delay.

Authors:  Tina Stuber; Hans-Jürgen Brambs; Wolfgang Freund; Markus S Juchems
Journal:  World J Radiol       Date:  2012-07-28

4.  Imaging of early pancreatic cancer on multidetector row helical computed tomography.

Authors:  K Takeshita; K Kutomi; T Haruyama; A Watanabe; S Furui; J Fukushima; T Asano
Journal:  Br J Radiol       Date:  2010-05-04       Impact factor: 3.039

Review 5.  Chronic pancreatitis: A diagnostic dilemma.

Authors:  Sinead N Duggan; Hazel M Ní Chonchubhair; Oladapo Lawal; Donal B O'Connor; Kevin C Conlon
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

6.  A deep learning algorithm to improve readers' interpretation and speed of pancreatic cystic lesions on dual-phase enhanced CT.

Authors:  Xiheng Wang; Zhaoyong Sun; Huadan Xue; Taiping Qu; Sihang Cheng; Juan Li; Yatong Li; Li Mao; Xiuli Li; Liang Zhu; Xiao Li; Longjing Zhang; Zhengyu Jin; Yizhou Yu
Journal:  Abdom Radiol (NY)       Date:  2022-03-27

7.  Establishment of optimal scan delay for multi-phase computed tomography using bolus-tracking technique in canine pancreas.

Authors:  Soo-Young Choi; Ho-Jung Choi; Ki-Ja Lee; Young-Won Lee
Journal:  J Vet Med Sci       Date:  2015-04-06       Impact factor: 1.267

8.  Arterial vs pancreatic phase: which is the best choice in the evaluation of pancreatic endocrine tumours with multidetector computed tomography (MDCT)?

Authors:  S Gusmini; R Nicoletti; C Martinenghi; C Caborni; G Balzano; A Zerbi; S I Rocchetti; P G Arcidiacono; L Albarello; F De Cobelli; V Di Carlo; A Del Maschio
Journal:  Radiol Med       Date:  2007-10-21       Impact factor: 6.313

9.  Optimal scan delay depending on contrast material injection duration in abdominal multi-phase computed tomography of pancreas and liver in normal Beagle dogs.

Authors:  Soo-Young Choi; In Lee; Ji-Won Seo; Hyun-Young Park; Ho-Jung Choi; Young-Won Lee
Journal:  J Vet Sci       Date:  2016-12-30       Impact factor: 1.672

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.